Affimed

-$0.06 (-0.68%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Affimed and other stocks, options, and ETFs commission-free!

About AFMD

Affimed NV engages in the discovery and development of cancer immunotherapies. It offers ROCK novel proprietary antibody platform, which delivers types of next-generation tetravalent antibody formats, including bispecific and trispecific innate cell engagers.

CEO
Adolf Hoess
Employees
163
Headquarters
Heidelberg, Baden Wuerttemberg
Founded
2000

AFMD Key Statistics

Market Cap
1.11B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.02M
High Today
$9.36
Low Today
$8.78
Open Price
$8.78
Volume
2.41M
52 Week High
$11.74
52 Week Low
$2.00

AFMD Earnings

-$0.21
-$0.14
-$0.07
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 22, Pre-Market
Replay Earnings Call

You May Also Like

FSLY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure